{"url_path":"/sec/celuw/8-k/2026-06-03/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1752828/0001493152-26-027132-index.html","accession_number":"0001493152-26-027132","cik":"0001752828","ticker":"CELU","issuer_name":"Celularity Inc","edgar_url":"https://www.sec.gov/Archives/edgar/data/1752828/0001493152-26-027132-index.html","primary_entity_key":"0001752828","primary_entity_name":"Celularity Inc"},"word_count":155,"has_tables":true,"body_markdown":"**Item\n5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of\nCertain Officers.**\n\n \n\nOn\nMay 29, 2026, Celularity Inc. (“Celularity”) appointed Rick Gonzalez as Chief Commercial Officer of Celularity. Mr. Gonzalez\nwill report directly to Robert J. Hariri, M.D., Ph.D., Celularity’s Chairman and Chief Executive Officer.\n\n \n\nCelularity\nhas not entered into a definitive employment agreement with Mr. Gonzalez in connection with his appointment. Celularity will disclose\nthe material terms of any definitive compensatory arrangement with Mr. Gonzalez in a subsequent filing with the Securities and Exchange\nCommission, as required.\n\n \n\nThere\nare no family relationships between Mr. Gonzalez and any director or executive officer of Celularity. There are no arrangements or understandings\nbetween Mr. Gonzalez and any other person pursuant to which he was appointed as Chief Commercial Officer. Mr. Gonzalez is not a party\nto any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K."}